Artificial intelligence is earning a place alongside radiologists in reading mammograms, CT scans, and pathology slides — not to replace expert judgment, but to sharpen it at the moments that matter most.
Decades of evidence showing proton therapy’s ability to protect developing brains in children with cancer are now driving a reassessment of how we treat adult brain tumors — with profound implications for quality of life.
A new generation of blood tests that detect cancer DNA circulating in the bloodstream is moving from research labs into clinical practice, promising to catch cancer earlier than any technology that came before.
CAR-T cell therapy transformed outcomes in leukemia and lymphoma. Now researchers are working to extend that success to solid tumors — and the progress, while real, reveals the complexity of what lies ahead.
Colorectal cancer is no longer primarily a disease of older adults. New data reveals a striking 50% increase in rates among people under 50 since 1994, prompting a landmark shift in screening guidelines.
Artificial intelligence is earning a place alongside radiologists in reading mammograms, CT scans, and pathology slides — not to replace expert judgment, but to sharpen it at the moments that matter most.
Decades of evidence showing proton therapy’s ability to protect developing brains in children with cancer are now driving a reassessment of how we treat adult brain tumors — with profound implications for quality of life.
A new generation of blood tests that detect cancer DNA circulating in the bloodstream is moving from research labs into clinical practice, promising to catch cancer earlier than any technology that came before.
CAR-T cell therapy transformed outcomes in leukemia and lymphoma. Now researchers are working to extend that success to solid tumors — and the progress, while real, reveals the complexity of what lies ahead.
Colorectal cancer is no longer primarily a disease of older adults. New data reveals a striking 50% increase in rates among people under 50 since 1994, prompting a landmark shift in screening guidelines.
